Abstract:The objective of the study was to prepare and characterize the inclusion complex of chrysin (CHR) with hydroxypropyl-β-cyclodextrin (HP-β-CD). The phase solubility study was performed to reveal supramolecular drug-ligand interactions between CHR with HP-β-CD. CHR/HP-β-CD inclusion complex was prepared using kneading, physical mixture, and coprecipitation method. Physicochemical characterization was performed using FTIR analysis, TGA, SEM, and 1H NMR analysis for CHR, HP-β-CD, and physical mixture (PM). A USP II dissolving test apparatus was utilized to determine the degree of solubility of both pure CHR and CHR/HP-β-CD complex. Results showed that increases in both CHR and HP-β-CD concentrations were directly proportional to increases in the complex's formation indicating perfect 1:1 stoichiometry. FTIR study showed that because of poly-hydroxyl activity of CHR/HP-β-CD inclusion complex. TGA analysis showed that sharpening of the endothermic peak at 287.69 °C was indicative of CHR melting. SEM analysis revealed that different sized plate-like clusters of crystals were seen in CHR, while amorphous shrinking thread-like particles were seen in HP-β-CD. CHR/HP-β-D inclusion complex displayed a uniform amorphous structure and no evidence of the typical plate-shaped CHR crystal. The presence of CHR causes chemical shifts of the H3 and H5 protons of HP-β-CD to differ significantly from those of the other protons. In vitro dissolution release study exhibited majority of the drug (62.5%) was found to be released within the first 20 min. The stabilizing effect of HP-β-CD was slightly attenuated in the alkaline media. The results showed that the resulting compound was more stable in water under physiologically relevant conditions. It can be concluded from the study that HP-β-CD is preferable to overcome the CHR's low aqueous solubility.

Synthesis, characterization and in vitro release studies of a new acetazolamide–HP-β-CD–TEA inclusion complex

Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment

Inclusion Complexes of Ethanamizuril with β- and Hydroxypropyl-β-Cyclodextrin in Aqueous Solution and in Solid State: A Comparison Study

New Mucoadhesive Polymeric Film for Ophthalmic Administration of Acetazolamide

Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development

Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide

Hybrid systems based on "drug - in cyclodextrin - in nanoclays" for improving oxaprozin dissolution properties

Preparation of inclusion complex of daidzein and hydropropyl-β- cyclodextrin

Development of direct compression Acetazolamide tablet with improved bioavailability in healthy human volunteers enabled by cocrystallization with p -Aminobenzoic acid

Inclusion Complex of Chrysin with Hydroxypropyl-β-cyclodextrin (HP-β-CD) Preparation, Characterization, and Dissolution Study

Chitosan microencapsulation of the dispersed phase of an O/W nanoemulsion to hydrochlorothiazide delivery

AAPS PharmSciTech volume 8, issue 4 — Editorial

Investigation the complex of 2,6-di-O-methyl-β-cyclodextrin and chlorzoxazone: preparation, characterization, dissolution, and cytotoxicity

Design and optimization of acetazolamide nanoparticle-laden contact lens using statistical experimental design for controlled ocular drug delivery

CYCLODEXTRIN DERIVATIVE ENHANCES THE OPHTHALMIC DELIVERY OF POORLY SOLUBLE AZITHROMYCIN

MODULATING THE DRUG SOLUBILITY OF ACECLOFENAC BY DESIGN AS SOLID LIPID PARTICLES: IN VITRO/IN VIVO CORRELATION

Solubility and Dissolution Enhancement of Candesartan Cilexetil by Complexation with Cyclodextrin

Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays

Preparation and Evaluation of in Situ Gelling Ophthalmic Drug Delivery System for Methazolamide

Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy